SCHEMBL19086545

SCHEMBL19086545

COC(=O)c1c(O)c2cc(C(=O)NC(c3ccccc3)c3ccccc3)ccc2n(C)c1=O

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 3/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 6/20 0.45
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
NLRP3 Q96P20 1/20 0.44
NPC1 O15118 2/20 0.44
ALOX15 P16050 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
GAA P10253 3/20 0.43
RAB9A P51151 1/20 0.43
S1PR4 O95977 1/20 0.42
S1PR3 Q99500 1/20 0.42
CYP3A4 P08684 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17578433 0.85 HIF1A (0.72) HIF1AL3MBTL1MEN1KMT2ANPC1
SCHEMBL23953030 0.85 HIF1A (0.48) HIF1AL3MBTL1ALDH1A1KDM4EMEN1
SCHEMBL19086578 0.83 HIF1A (0.60) HIF1AL3MBTL1KDM4EMEN1KMT2A
SCHEMBL19086684 0.82 HIF1A (0.73) HIF1AL3MBTL1ALDH1A1KDM4EMEN1
SCHEMBL19086870 0.78 NPC1 (0.53) HIF1AALDH1A1KDM4EMEN1KMT2A
SCHEMBL19086664 0.76 HIF1A (0.71) HIF1AALDH1A1KDM4EGAA
SCHEMBL1685954 0.75 ALDH1A1 (0.72) L3MBTL1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL19086553 0.75 HPGDS (0.46) ALDH1A1KDM4EMEN1KMT2ARXFP1
SCHEMBL19086606 0.74 ALDH1A1 (0.57) HIF1AALDH1A1KDM4EMEN1KMT2A
SCHEMBL2545775 0.74 ALDH1A1 (0.66) L3MBTL1ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3190104-B1 QUINOLINONE COMPOUND AND USE THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2021-10-27 EP disclosed
US-10065928-B2 Quinolinone compound and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2018-09-04 US disclosed
US-20170247332-A1 QUINOLINONE COMPOUND AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-08-31 US disclosed
EP-3190104-A1 QUINOLINONE COMPOUND AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2017-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247332-A1 QUINOLINONE COMPOUND AND USE THEREOF HIF1AN, HIF1A, EGLN2 HIF1A 2/4885L3MBTL1 4028/4885ALDH1A1 517/4885
US-10065928-B2 Quinolinone compound and use thereof HIF1AN, HIF1A, EGLN2 HIF1A 2/4885L3MBTL1 4028/4885ALDH1A1 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.